Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma

ABSTRACT: As a first-line drug for treating advanced hepatocellular carcinoma, the resistance to sorafenib has always attracted attention. However, most attention has been focused on a series of mechanisms related to drug resistance caused after sorafenib treatment. In this study, we used proteomic techniques to explore the potential mechanisms by which pre-treatment factors affect sorafenib resistance.

ORGANISM(S): Homo Sapiens

SUBMITTER: Wantao Ying  

PROVIDER: PXD040371 | iProX | Fri Feb 24 00:00:00 GMT 2023

REPOSITORIES: iProX